Ionpath delivers high definition spatial proteomics, revolutionizing tissue imaging and analysis to accelerate discovery and improve human health. Ionpath’s MIBI™ (multiplexed ion beam imaging) Platform breaks through the limitations of traditional IHC, enabling deep understanding of the tissue microenvironment with highly multiplexed quantitative single-cell analysis. With MIBI technology and the expertise of world class pathology and data science teams, Ionpath provides actionable insights to translational and clinical researchers at leading pharma, biotech, and research organizations in immuno-oncology, immunology, neuroscience and infectious disease research.
Company Details
- Employees
- 15
- Founded
- -
- Address
- 960 Obrien Dr, Menlo Park,california 94025,united States
- pa****@****ath.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- ionpath.com
- Keywords
- mass spectrometry, pathology, cancer, neuroscience, MIBI, spatial proteomics, immuno-oncology, multiplexed tissue imaging, translational research, autoimmune disease, precision medicine.
- HQ
- Menlo Park, California
Ionpath Questions
Ionpath's website is ionpath.com
Ionpath's LinkedIn profile is https://www.linkedin.com/company/ionpath
Ionpath has
15 employees.
View email and phone details for 15
employees at Ionpath.
Ionpath's industry is
Biotechnology Research
Ionpath's top competitors are
10x Genomics,
Rebus Biosystems,
Vizgen,
Curio Bioscience,
Stellaromics Inc.,
Ultima Genomics,
Akoya Biosciences, Inc.,
Ultivue By Vizgen,
Advanced Cell Diagnostics (Acd),
Parse Biosciences.
Ionpath's support email address is partnerships@ionpath.com
Ionpath's categories are Biotechnology Research
Ionpath's founding year is 2014
